XML 141 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Segmented Information
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Segmented Information [Abstract]    
SEGMENTED INFORMATION

NOTE 14 — SEGMENTED INFORMATION

The Company currently operates in a single reportable operating segment, being the researching and developing pharmaceutical treatments for neurological diseases in the geographical areas of Canada and the United States of America. Geographic information for the United States and Canada as of June 30, 2024, and December 31, 2023, is as follows:

 

As of June 30, 2024

   

Canada

 

United States

 

Total

Non-current assets other than financial instruments

 

$

452,683

 

$

1,054

 

$

453,737

 

As of December 31, 2023

   

Canada

 

United States

 

Total

Non-current assets other than financial instruments

 

$

532,276

 

$

1,455

 

$

533,731

NOTE 14 — SEGMENTED INFORMATION

The Company currently operates in a single reportable operating segment, being the researching and developing pharmaceutical treatments for neurological diseases in the geographical areas of Canada and the United States of America. Geographic information for the United States and Canada as of December 31, 2023 and 2022 is as follows:

 

As at December 31, 2023

   

Canada

 

United States

 

Total

Non-current assets other than financial instruments

 

$

532,276

 

$

1,455

 

$

533,731

 

As at December 31, 2022

   

Canada

 

United States

 

Total

Non-current assets other than financial instruments

 

$

614,977

 

$

3,233

 

$

618,210